title: Outcomes of an educational-outreach service for community medical practitioners: non-steroidal anti-inflammatory drugs.
abstract: OBJECTIVE
  Exploration of longer-term outcomes of an ongoing educational-outreach service for community doctors.
  
  
  METHODS
  Quasi-experimental, with parallel and historical comparisons.
  
  
  METHODS
  Since 1992, a teaching-hospital-based service has been providing advice and information on drugs and therapeutic strategies to community medical practitioners.
  
  
  METHODS
  210 doctors practising in a particular area of metropolitan Adelaide (79% general practitioners; 21% specialists).
  
  
  METHODS
  Two surgery visits during 1992 focused on better use of prescribed non-steroidal anti-inflammatory drugs (NSAIDs). Subsequent visits on other topical therapeutic issues have occurred regularly.
  
  
  METHODS
  Doctor participation in the service; supply of prescription NSAIDs; hospital admissions for gastrointestinal (GI) effects of NSAID use.
  
  
  RESULTS
  89% of doctors practising within the service area received the first visit on NSAIDs and 86% received the second visit. More than 85% continue to receive the service. Relative to a comparison area, aggregate reductions of 9% and 28%, respectively, were observed in two different measures of NSAID use. During an 11-year observation period, a single change point in the number of hospital admissions for GI disorders occurred in the service area, coinciding with delivery of the NSAID program. In the five years since the visits commenced, a 70% reduction in admissions was observed. No notable changes in hospital admission rates occurred in the comparison area.
  
  
  CONCLUSIONS
  A continuing education and support service for community medical practitioners which uses principally academic detailing methods in its contact with doctors has contributed to sustained changes in prescribed NSAID use over a five-year period. A focus on risk-minimisation in prescribing of NSAIDs appears to have contributed to reductions in hospitalisations for GI adverse events.
authors.affiliation: Pharmacy Department, Repatriation General Hospital, Daw Park, SA. smayf@rgh.sa.gov.au
authors.forename: F W
authors.initials: FW
authors.lastname: May
authors.forename: D S
authors.initials: DS
authors.lastname: Rowett
authors.forename: A L
authors.initials: AL
authors.lastname: Gilbert
authors.forename: J I
authors.initials: JI
authors.lastname: McNeece
authors.forename: E
authors.initials: E
authors.lastname: Hurley
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000009:adverse effects; D015331:Cohort Studies; D003154:Community Medicine / Q000193:education*; D020000:Decision Support Systems, Clinical; D004346:Drug Information Services; D011307:Drug Prescriptions; D004363:Drug Utilization; D004501:Education, Medical; D004502:Education, Medical, Continuing; D004512:Education, Pharmacy; D005194:Family Practice / Q000193:education; D005260:Female; D005500:Follow-Up Studies; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006784:Hospitals, Teaching; D006801:Humans; D008297:Male; D017063:Outcome Assessment, Health Care; D010343:Patient Admission; D013021:South Australia; D013038:Specialization
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal